Switzerland Archives

Latest Posts

Sophia Genetics is the first European bioinformatic company allowed to analyze clinical genetic data

News and Trends 17 Sep 2014

Sophia Genetics: the first European bioinformatic company allowed to analyze clinical genetic data

Sophia Genetics has become the first European company to obtain a CE-IVD mark allowing the use of their bioinformatic algorithms to analyse clinical data obtained through Next Generation Sequencing. This certification is an important step in making these in the standard use of routine genetic testing and clinical diagnosis. It brings Sophia Genetics’ world-leading Data Driven Medicine platform to […]

September 17, 2014 - 2 minutesmins - By Julie Lellouche

News and Trends 4 Sep 2014

Art Levinson says goodbye to Roche and will focus on Calico’s development

Roche announced today that Arthur D. Levinson has resigned from the Board of Directors, effective immediately. Arthur D. Levinson made this decision so as to avoid any conflict of interest given his role as Chief Executive Officer at Calico. “I would like to thank Art for his many important contributions, both as a member […]

September 4, 2014 - 3 minutesmins - By Joachim Eeckhout

News and Trends 25 Aug 2014

The new strategy of Novartis to acquire Gamida Cell

The deal for the sale of Gamida Cell to Novartis is back on. Instead of a huge exit in hundreds of millions of dollars, this time the deal is in multiple stages, starting with an injection of several dozen millions of dollars into the company. Gamida Cell, developer of a stem-cell treatment for blood cancer, announced today that it […]

August 25, 2014 - 2 minutesmins - By Joachim Eeckhout

News and Trends 21 Aug 2014

Stemedica International succeed in a pre-clinical trial to treat Alzheimer’s disease with stem cells

Stemedica International, a Stemedica Cell Technologies Inc. subsidiary developing stem cell therapies for Alzheimer’s disease and dementia, revealed the first results of an intravenous administration of allogeneic, human, ischemia-tolerant mesenchymal stem cells (itMSCs) in a pre-clinical animal model of Alzheimer’s disease. The results demonstrated a greater than 30% decrease in amyloid beta (Abeta) plaques in […]

August 21, 2014 - 2 minutesmins - By Joachim Eeckhout

News and Trends 15 Aug 2014

Active Biotech and Teva together in a Phase II clinical trial against Huntington’s disease

Active Biotech announced today that its partner Teva Pharmaceutical will initiate a phase II clinical trial to evaluate the efficacy and safety of oral laquinimod for the treatment of Huntington’s disease. Laquinimod is a once-daily oral, investigational, CNS-active immunomodulator with a novel mechanism of action being developed primarily for the treatment of relapsing-remitting multiple sclerosis […]

August 15, 2014 - 1 minutemin - By Joachim Eeckhout

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Switzerland

Sophia Genetics: the first European bioinformatic company allowed to analyze clinical genetic data

Art Levinson says goodbye to Roche and will focus on Calico’s development

The new strategy of Novartis to acquire Gamida Cell

Stemedica International succeed in a pre-clinical trial to treat Alzheimer’s disease with stem cells

Active Biotech and Teva together in a Phase II clinical trial against Huntington’s disease

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!